ResMed Inc (RSMDF) stock
RSMDFOTCSurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RMD
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026Score 21/3011% below fair value
$22.61+0.00 (0.00%)
Close on Oct 19, 2026Market cap $33.17BP/E 22.0Yield 1.04%
ResMed revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
ResMed's revenue for the twelve months ending Jun 30, 2026 was $5.65B, up 9.9% year over year. For fiscal 2026 it was $5.65B, up 9.9% from the year before. Over ten years it grew 11.9% a year on average. The highest annual figure on record is $5.65B in fiscal 2026.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $5.65B | +9.9% |
| FY2025 | Jun 30, 2025 | $5.15B | +9.8% |
| FY2024 | Jun 30, 2024 | $4.69B | +10.9% |
| FY2023 | Jun 30, 2023 | $4.22B | +18.0% |
| FY2022 | Jun 30, 2022 | $3.58B | +11.9% |
| FY2021 | Jun 30, 2021 | $3.20B | +8.1% |
| FY2020 | Jun 30, 2020 | $2.96B | +13.4% |
| FY2019 | Jun 30, 2019 | $2.61B | +11.4% |
| FY2018 | Jun 30, 2018 | $2.34B | +13.2% |
| FY2017 | Jun 30, 2017 | $2.07B | +12.4% |
| FY2016 | Jun 30, 2016 | $1.84B | +9.5% |
| FY2015 | Jun 30, 2015 | $1.68B | +8.0% |
| FY2014 | Jun 30, 2014 | $1.55B | +2.7% |
| FY2013 | Jun 30, 2013 | $1.51B | +10.7% |
| FY2012 | Jun 30, 2012 | $1.37B | +10.1% |
| FY2011 | Jun 30, 2011 | $1.24B | +13.8% |
| FY2010 | Jun 30, 2010 | $1.09B | +18.6% |
| FY2009 | Jun 30, 2009 | $920.74M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026 | Jun 30, 2026 | $1.46B | +8.6% |
| Q3 FY2026 | Mar 31, 2026 | $1.43B | +10.8% |
| Q2 FY2026 | Dec 31, 2025 | $1.42B | +11.0% |
| Q1 FY2026 | Sep 30, 2025 | $1.34B | +9.1% |
| Q4 FY2025 | Jun 30, 2025 | $1.35B | +10.2% |
| Q3 FY2025 | Mar 31, 2025 | $1.29B | +7.9% |
| Q2 FY2025 | Dec 31, 2024 | $1.28B | +10.3% |
| Q1 FY2025 | Sep 30, 2024 | $1.22B | +11.1% |
| Q4 FY2024 | Jun 30, 2024 | $1.22B | +9.0% |
| Q3 FY2024 | Mar 31, 2024 | $1.20B | +7.2% |
| Q2 FY2024 | Dec 31, 2023 | $1.16B | +12.5% |
| Q1 FY2024 | Sep 30, 2023 | $1.10B | +16.0% |
| Q4 FY2023 | Jun 30, 2023 | $1.12B | +22.7% |
| Q3 FY2023 | Mar 31, 2023 | $1.12B | +29.2% |
| Q2 FY2023 | Dec 31, 2022 | $1.03B | +15.5% |
| Q1 FY2023 | Sep 30, 2022 | $950.29M | +5.1% |
| Q4 FY2022 | Jun 30, 2022 | $914.74M | +4.4% |
| Q3 FY2022 | Mar 31, 2022 | $864.50M | +12.5% |
| Q2 FY2022 | Dec 31, 2021 | $894.87M | +11.9% |
| Q1 FY2022 | Sep 30, 2021 | $904.02M | +20.2% |
| Q4 FY2021 | Jun 30, 2021 | $876.10M | +13.7% |
| Q3 FY2021 | Mar 31, 2021 | $768.77M | -0.1% |
| Q2 FY2021 | Dec 31, 2020 | $800.01M | +8.7% |
| Q1 FY2021 | Sep 30, 2020 | $751.94M | +10.4% |
| Q4 FY2020 | Jun 30, 2020 | $770.34M | +9.3% |
| Q3 FY2020 | Mar 31, 2020 | $769.46M | +16.2% |
| Q2 FY2020 | Dec 31, 2019 | $736.16M | +13.1% |
| Q1 FY2020 | Sep 30, 2019 | $681.06M | +15.8% |
| Q4 FY2019 | Jun 30, 2019 | $704.96M | +13.0% |
| Q3 FY2019 | Mar 31, 2019 | $662.23M | +11.9% |
| Q2 FY2019 | Dec 31, 2018 | $651.10M | +8.3% |
| Q1 FY2019 | Sep 30, 2018 | $588.28M | +12.3% |
| Q4 FY2018 | Jun 30, 2018 | $623.63M | +12.0% |
| Q3 FY2018 | Mar 31, 2018 | $591.63M | +15.1% |
| Q2 FY2018 | Dec 31, 2017 | $601.27M | +13.4% |
| Q1 FY2018 | Sep 30, 2017 | $523.66M | +12.5% |
| Q4 FY2017 | Jun 30, 2017 | $556.69M | – |
| Q3 FY2017 | Mar 31, 2017 | $514.20M | – |
| Q2 FY2017 | Dec 31, 2016 | $530.40M | – |
| Q1 FY2017 | Sep 30, 2016 | $465.45M | – |